Tailored neoadjuvant epiruhicin and cyclopbosphatnide and nanoparticle albumin bound (nab)-paditaxel for newly diagnosed breast cancer Meeting Abstract


Authors: Khasraw, M.; West, L.; Duan, W.; Mukaro, V.; Harvey, S.; Spokes, R.; Brandt, C.; Mitchell, G.; Prince, K.; Hayes, T. M.; Baron-Hay, S. E.; Woollett, A. M.; Olesen, I. H.; White, K.; Bowles, S.; Wong, S. F.; Ashley, D. M.; Patil, S.
Abstract Title: Tailored neoadjuvant epiruhicin and cyclopbosphatnide and nanoparticle albumin bound (nab)-paditaxel for newly diagnosed breast cancer
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613201992
PROVIDER: wos
DOI: 10.1200/jco.2014.32.15_suppl.tps1135
Notes: Meeting Abstract: TPS1135 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sujata Patil
    511 Patil